deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 1-arm NCT03266588

Open Label Safety Study in Acute Treatment of Migraine

A Multicenter, Open Label Long-Term Safety Study of BHV-3000 in the Acute Treatment of Migraine

Sponsor: Pfizer

Conditions Migraine, With or Without Aura
Interventions Rimegepant
Updated 21 times since 2017 Last updated: Feb 14, 2023 Started: Aug 30, 2017 Primary completion: Jul 15, 2019 Completion: Jul 15, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03266588, this PHASE2/PHASE3 trial focuses on Migraine, With or Without Aura and remains completed. Sponsored by Pfizer, it has been updated 21 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Sep 2017 – ~Oct 2017 · 30 days · monthly snapshot~Oct 2017 – ~Nov 2017 · 31 days · monthly snapshot~Nov 2017 – ~Dec 2017 · 30 days · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Dec 2018 · 2 months · monthly snapshot~Dec 2018 – ~Feb 2019 · 2 months · monthly snapshot~Feb 2019 – ~Apr 2019 · 59 days · monthly snapshot~Apr 2019 – ~Sep 2019 · 5 months · monthly snapshot~Sep 2019 – ~Aug 2020 · 11 months · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Jan 2023 · 24 months · monthly snapshot~Jan 2023 – ~Mar 2023 · 59 days · monthly snapshot~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

21 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  4. Mar 2023 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  5. Jan 2023 — Mar 2023 [monthly]

    Completed PHASE2_PHASE3

▶ Show 16 earlier versions

  1. Jan 2021 — Jan 2023 [monthly]

    Completed PHASE2_PHASE3

  2. Sep 2020 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

  3. Aug 2020 — Sep 2020 [monthly]

    Completed PHASE2_PHASE3

  4. Sep 2019 — Aug 2020 [monthly]

    Completed PHASE2_PHASE3

    Status: Active Not Recruiting → Completed

  5. Apr 2019 — Sep 2019 [monthly]

    Active Not Recruiting PHASE2_PHASE3

    Status: Recruiting → Active Not Recruiting

  6. Feb 2019 — Apr 2019 [monthly]

    Recruiting PHASE2_PHASE3

    Status: Active Not Recruiting → Recruiting

  7. Dec 2018 — Feb 2019 [monthly]

    Active Not Recruiting PHASE2_PHASE3

  8. Oct 2018 — Dec 2018 [monthly]

    Active Not Recruiting PHASE2_PHASE3

    Status: Recruiting → Active Not Recruiting

  9. Sep 2018 — Oct 2018 [monthly]

    Recruiting PHASE2_PHASE3

  10. Aug 2018 — Sep 2018 [monthly]

    Recruiting PHASE2_PHASE3

  11. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE2_PHASE3

  12. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE2_PHASE3

  13. Dec 2017 — Jun 2018 [monthly]

    Recruiting PHASE2_PHASE3

  14. Nov 2017 — Dec 2017 [monthly]

    Recruiting PHASE2_PHASE3

  15. Oct 2017 — Nov 2017 [monthly]

    Recruiting PHASE2_PHASE3

    Status: Not Yet Recruiting → Recruiting

  16. Sep 2017 — Oct 2017 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

    First recorded

Aug 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Pfizer
Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Ames, United States , Anderson, United States , Ann Arbor, United States , Atlanta, United States , Augusta, United States , Austin, United States , Bellevue, United States , Berlin, United States , Binghamton, United States and 79 more locations